Topical Collection on Myeloproliferative Neoplasms
In this topical collection (40 articles)
-
Myeloproliferative Neoplasms (P Bose, Section Editor)
Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms
Barbara Mora, Francesco Passamonti Pages 127-139 -
Myeloproliferative Neoplasms (B Stein, Section Editor)
Novel Therapies in Polycythemia Vera
Douglas Tremblay, John Mascarenhas Pages 133-140 -
Myeloproliferative Neoplasms (B Stein, Section Editor)
Next-Generation Sequencing in Myeloproliferative Neoplasms: Is This Indicated in All Patients?
Alain Antoine Mina, Brady Stein Pages 137-144 -
Myeloproliferative Neoplasms (P Bose, Section Editor)
Novel Therapies in Myelofibrosis: Beyond JAK Inhibitors
Julian A. Waksal, John Mascarenhas Pages 140-154 -
Myeloproliferative Neoplasms (B Stein, Section Editor)
Myeloproliferative Neoplasms in Children, Adolescents, and Young Adults
Nicole Kucine Pages 141-148 -
Myeloproliferative Neoplasms (B Stein, Section Editor)
Key Role of Inflammation in Myeloproliferative Neoplasms: Instigator of Disease Initiation, Progression. and Symptoms
Laura F. Mendez Luque, Amanda L. Blackmon… Pages 145-153 -
Myeloproliferative Neoplasms (B Stein, Section Editor)
Chronic Myelomonocytic Leukemia: 2018 Update to Prognosis and Treatment
Hany Elmariah, Amy E. DeZern Pages 154-163 -
Myeloproliferative Neoplasms (P Bose, Section Editor)
Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia
Ivan Krecak, Marko Lucijanic, Srdan Verstovsek Pages 155-169 -
Myeloproliferative Neoplasms (B Stein, Section Editor)
Integrative Approaches to Managing Myeloproliferative Neoplasms: the Role of Nutrition, Exercise, and Psychological Interventions
Prathibha Surapaneni, Robyn M. Scherber Pages 164-170 -
Myeloproliferative Neoplasms (B Stein, Section Editor)
Management of Myelofibrosis-Related Cytopenias
Prithviraj Bose, Srdan Verstovsek Pages 164-172 -
Myeloproliferative Neoplasms (B Stein, Section Editor)
Post-ET and Post-PV Myelofibrosis: Updates on a Distinct Prognosis from Primary Myelofibrosis
Francesco Passamonti, Barbara Mora… Pages 173-182 -
ReviewPaper
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative Diseases
Andrea Duminuco, Elena Torre, Giuseppe A. Palumbo… Pages 176-189 -
Myeloproliferative Neoplasms (B Stein, Section Editor)
Splanchnic Vein Thrombosis in the Myeloproliferative Neoplasms
Imo J. Akpan, Brady Lee Stein Pages 183-190 -
Myeloproliferative Neoplasms (B Stein, Section Editor)
Diagnosis and Novel Approaches to the Treatment of Hypereosinophilic Syndromes
Melanie C. Dispenza, Bruce S. Bochner Pages 191-201 -
Myeloproliferative Neoplasms (B Stein, Section Editor)
Tyrosine Kinase Inhibitors in the Treatment of Chronic-Phase CML: Strategies for Frontline Decision-making
James A. Kennedy, Gabriela Hobbs Pages 202-211 -
Myeloproliferative Neoplasms (B Stein, Section Editor)
Thrombocytosis and Thrombosis: Is There Really a Correlation?
Carlos Galvez, Brady L. Stein Pages 261-267 -
Myeloproliferative Neoplasms (B Stein, Section Editor)
Novel Pathophysiological Mechanisms of Thrombosis in Myeloproliferative Neoplasms
Brandi N. Reeves, Joan D. Beckman Pages 304-313
![Current Hematologic Malignancy Reports](https://static-content.springer.com/cover/journal/11899/0/0.jpg)
Continue reading...
To view the rest of this content please follow the download PDF link above.